by
Glenn Cockerham, MD, SES, EQV
;
Devan Kansagara, MD, MCR
;
Deborah Khachikian, PharmD
;
Allison Low, BA
Seminar date: 5/10/2017
Description: Report authors will summarize the findings of the following research questions: 1) What is the comparative clinical effectiveness of anti-VEGF agents for retinal/choroidal neovascularization and/or macular edema in adults?; 2) What are the comparative harms of anti-VEGF agents for retinal/choroidal neovascularization and/or macular edema in adults?; 3) What is the comparative cost-effectiveness of anti-VEGF? Key stakeholders and Operational Partners will make up a panel of discussants and be available for questions. Intended audience: Researchers and clinicians interested in visual impairment and treatment options for Veterans.
DOWNLOAD: Request PDF Handout | Audio only (mp3) | transcript
